INJECTABLE SOLUTION WITH ANTI-INFLAMMATORY EFFECT AND PROCESS FOR MANUFACTURING THE SAME
An easy technology, for obtaining a medicine with the next advantages: anti-allergic, anti-inflammatory, anti-toxic, anti-viral, drug-dependence-losing, immuno-modulator, side-effects-free, for treating the ensuing diseases: autoimmune, neurologic, endocrine, infective, hepatic, renal and cancer. We seek a transfer of technology by means of licenses.
The technology, consists of the following steps:
--The cleaning and the drying of the YMPHYTUM OFFICINALE medicinal plant’s roots.
--The calcination of the roots, in therm-resistant containers transforming it in a grey ash free of the pirrolisidinic alkaloids with deleterious effects.
--The solving of the ash in distilled water, in certain proportion.
--The filtering of the obtained solution, by means of 3 types of filters.
--The filtrate is subjected to boiling evaporation, till to a certain viscosity.
--The viscid product, is subjected to a second drying, till one obtain an not-adherent white powder.
--The powder is introduced and kept in tight glass containers.
--For the inject able solution, the powder is solved, in 3 different solvents (according to the kind of use, in children, adults or old people).
--The use for different diseases, is treated in the KNOW-HOW.
The powder was examined with the next analyses: chemical, I.R. ,stoichiometrically, X-ray microanalysis; one found a predominance of inorganic elements and between these ,in the most proportion were potassium and sulphure and as traces was cassiopeum.
The innovative Aspects, are:
1) the simplicity of the technology, which leads to the obtaining of a valuable product emphasized, by the possibility to heal various diseases, which hadn’t a safe treatment.
2)Some spectacular results, how the product, successive to the applying of the technology, achieve, a medicine with a supplementary potential.
3)The same SITE, suggest us the new horizons(in STEM CELLS and NANOTECHNOLOGY,researches) opened.
The anti-inflammatory, anti-toxic and immuno-modulator actions, determined by the medicine obtained through the technology described are the basic effects for a safe health.
The effects of the product obtained by the exposed technology, was tested of hundred of cases.
European Patent nb. 1 343 512 B 1 and
United States Patent U S 7,604,822 B2
The research was applied of hundreds of cases, by Dr.ELENA IONASCU( after having applied by myself, on my self, having a deforming polyarthritis, and on my relations: one ,with DEPERSONALIZATION disorders, and the other with a bladder cancer operated and with a 3 cm. pulmonary .metastasis in 1994, both surviving after 17 years after the treatment with the product, through the technology discussed.
To obtain all the necessary approvals for to be put on the market